ISBN13: | 9780443187032 |
ISBN10: | 0443187037 |
Kötéstípus: | Keménykötés |
Terjedelem: | 622 oldal |
Méret: | 276x216 mm |
Nyelv: | angol |
700 |
Management, Body Systems, and Case Studies in COVID-19
EUR 220.00
Kattintson ide a feliratkozáshoz
- Discusses the management of multisystem symptomatology, including neurological, hematological, hepatobiliary, gastrointestinal, and cardiovascular systems
- Outlines several neurological conditions, including brain embolism, brain cancer, meningoencephalitis, and smell and taste disorders
- Features individual chapter introductions, summaries, and a section on case studies to provide a comprehensive introduction to the topic
- Describes guidelines for clinics providing neurological care for COVID-19 patients
Preface I. Introductory chapters and setting the scene 1. Hand hygiene strategies 2. Approved vaccines for the COVID-19 pandemic: linking in future perspectives 3. RT-PCR methods for SARS-CoV-2 variants II. Management 4. Systematic Patient assessment for Acute Respiratory Tract Ailments (SPARTA): A simple tool to improve outcomes from COVID-19 5. Point of Care Ultrasound: for COVID-19: The Multi-organ Approach to COVID-19 6. COVID-19 in patients with inflammatory bowel diseases: features and guidelines 7. Management of COVID-19 and clinical nutrition 8. The management of head and neck cancer patients in COVID-19 9. The COVID-19 pandemic: inventory management and allocation of personal protective equipment (PPE) 10. Clinical management in the COVID-19 pandemic: rheumatic disease 11. Managing migraine in the COVID-19 pandemic 12. Perioperative management of patients undergoing endovascular thrombectomy for ischemic stroke during COVID pandemic 13. COVID-19 and the management of blood pressure in outpatients 14. Neurosurgical trauma management during COVID-19 restrictions 15. The COVID-19 pandemic and management of weight gain: implications for obesity 16. COVID-19 and the management of heart failure using telemedicine III. Guidelines for different treatment clinics 17. Guidelines for breast imaging in the COVID-19 pandemic 18. Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis, guidelines and reporting 19. Guidelines on surgical management in the COVID-19 pandemic 20. Multisystem inflammatory syndrome in children (MIS-C)/Paediatric inflammatory multisystem syndrome (PIMS): clinical guidelines. IV. Impact on the respiratory system 21. Ground-glass nodules in the lung of COVID-19 patients 22. Cardiothoracic imaging in COVID-19 patients 23. Cystic fibrosis and bronchial epithelial cells in SARS-CoV-2 infection 24. Biomechanics and mechanobiology of the lung parenchyma following SARS-CoV-2 infection 25. Long noncoding RNA profiling in respiratory specimens from COVID-19 patients 26. COVID-19 and acute pulmonary embolism 27. The usefulness of alveolar-arteriolar gradient during COVID-19 pandemic V. Effects on cardiovascular and haematological systems 28. Cardiac effects of COVID-19 an overview 29. Limb ischemia and COVID-19 30. Thrombosis and coagulopathy in COVID-19: a new narrative 31. COVID-19 myocarditis: features of echocardiography 32. COVID-19 lockdown and impact on arrhythmias 33. Cardiometabolic disease and COVID-19: A new narrative 34. Post recovery COVID-19 and interlinking diabetes and cardiovascular events 35. COVID-19 patients and extracorporeal membrane oxygenation 36. Hematological aspects of SARS- COV- 2 infection VI. Effects on body systems 37. Dermatological reactions associated with personal protective equipment (PPE) use during the COVID-19 pandemic 38. Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccines' response 39. Co-infections with COVID-19: a focus on tuberculosis (TB) 40. Patients with autoimmune liver disease and the impact of SARS-CoV-2 infection 41. COVID-19 severity and nonalcoholic fatty liver disease 42. The impact of the COVID-19 pandemic on severity of obesity 43. The diabetic patient and concomitant conditions rhino-orbital-cerebral mucormycosis and COVID-19 44. Tissue location of SARS-CoV-2 RNA: a focus on bone and implications for skeletal health 45. Linking gastrointestinal tract effects of COVID-19 and tryptophan metabolism 46. Organ damage in SARS-CoV-2 infection in children: a focus on acute kidney injury 47. Obesity, COVID-19 severity and mortality 48. Upper and lower gastrointestinal symptoms and complications among COVID-19 patients 49. The COVID-19 Survivors: impact on skeletal muscle strength VII. Case studies with mini review 50. CASE STUDY: COVID-19-and meningoencephalitis 51. CASE STUDY: Oral mucosal lesions in COVID-19 52. CASE STUDY: COVID-19 Pneumonia 53. CASE STUDY: Optic neuritis in SARS-CoV-2 infection VIII. Resources 54. Recommended Resources Relevant to the Body Systems Involvement and Management of COVID-19